The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCO 2024 | Current and future treatment options for patients with myelofibrosis who have anemia
Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the current treatment options for patients with myelofibrosis (MF) who have anemia and highlights some agents currently under investigation. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
